1362 related articles for article (PubMed ID: 26627737)
1. High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities.
Hart T; Chandrashekhar M; Aregger M; Steinhart Z; Brown KR; MacLeod G; Mis M; Zimmermann M; Fradet-Turcotte A; Sun S; Mero P; Dirks P; Sidhu S; Roth FP; Rissland OS; Durocher D; Angers S; Moffat J
Cell; 2015 Dec; 163(6):1515-26. PubMed ID: 26627737
[TBL] [Abstract][Full Text] [Related]
2. Evaluation and Design of Genome-Wide CRISPR/SpCas9 Knockout Screens.
Hart T; Tong AHY; Chan K; Van Leeuwen J; Seetharaman A; Aregger M; Chandrashekhar M; Hustedt N; Seth S; Noonan A; Habsid A; Sizova O; Nedyalkova L; Climie R; Tworzyanski L; Lawson K; Sartori MA; Alibeh S; Tieu D; Masud S; Mero P; Weiss A; Brown KR; Usaj M; Billmann M; Rahman M; Constanzo M; Myers CL; Andrews BJ; Boone C; Durocher D; Moffat J
G3 (Bethesda); 2017 Aug; 7(8):2719-2727. PubMed ID: 28655737
[TBL] [Abstract][Full Text] [Related]
3. CRISPR-Cas9 screens reveal common essential miRNAs in human cancer cell lines.
Merk DJ; Paul L; Tsiami F; Hohenthanner H; Kouchesfahani GM; Haeusser LA; Walter B; Brown A; Persky NS; Root DE; Tabatabai G
Genome Med; 2024 Jun; 16(1):82. PubMed ID: 38886809
[TBL] [Abstract][Full Text] [Related]
4. Identification of oncogenic driver mutations by genome-wide CRISPR-Cas9 dropout screening.
Kiessling MK; Schuierer S; Stertz S; Beibel M; Bergling S; Knehr J; Carbone W; de Vallière C; Tchinda J; Bouwmeester T; Seuwen K; Rogler G; Roma G
BMC Genomics; 2016 Sep; 17(1):723. PubMed ID: 27613601
[TBL] [Abstract][Full Text] [Related]
5. CoRe: a robustly benchmarked R package for identifying core-fitness genes in genome-wide pooled CRISPR-Cas9 screens.
Vinceti A; Karakoc E; Pacini C; Perron U; De Lucia RR; Garnett MJ; Iorio F
BMC Genomics; 2021 Nov; 22(1):828. PubMed ID: 34789150
[TBL] [Abstract][Full Text] [Related]
6. Partial gene suppression improves identification of cancer vulnerabilities when CRISPR-Cas9 knockout is pan-lethal.
Krill-Burger JM; Dempster JM; Borah AA; Paolella BR; Root DE; Golub TR; Boehm JS; Hahn WC; McFarland JM; Vazquez F; Tsherniak A
Genome Biol; 2023 Aug; 24(1):192. PubMed ID: 37612728
[TBL] [Abstract][Full Text] [Related]
7. Pooled genome-wide CRISPR screening for basal and context-specific fitness gene essentiality in
Viswanatha R; Li Z; Hu Y; Perrimon N
Elife; 2018 Jul; 7():. PubMed ID: 30051818
[TBL] [Abstract][Full Text] [Related]
8. A High-Resolution Genome-Wide CRISPR/Cas9 Viability Screen Reveals Structural Features and Contextual Diversity of the Human Cell-Essential Proteome.
Bertomeu T; Coulombe-Huntington J; Chatr-Aryamontri A; Bourdages KG; Coyaud E; Raught B; Xia Y; Tyers M
Mol Cell Biol; 2018 Jan; 38(1):. PubMed ID: 29038160
[TBL] [Abstract][Full Text] [Related]
9. Improved analysis of CRISPR fitness screens and reduced off-target effects with the BAGEL2 gene essentiality classifier.
Kim E; Hart T
Genome Med; 2021 Jan; 13(1):2. PubMed ID: 33407829
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-focused CRISPR-Cas9 library screen reveals fitness-associated miRNAs.
Kurata JS; Lin RJ
RNA; 2018 Jul; 24(7):966-981. PubMed ID: 29720387
[TBL] [Abstract][Full Text] [Related]
11. Analysis of CRISPR-Cas9 screens identifies genetic dependencies in melanoma.
Christodoulou E; Rashid M; Pacini C; Droop A; Robertson H; Groningen TV; Teunisse AFAS; Iorio F; Jochemsen AG; Adams DJ; Doorn RV
Pigment Cell Melanoma Res; 2021 Jan; 34(1):122-131. PubMed ID: 32767816
[TBL] [Abstract][Full Text] [Related]
12. Unsupervised correction of gene-independent cell responses to CRISPR-Cas9 targeting.
Iorio F; Behan FM; Gonçalves E; Bhosle SG; Chen E; Shepherd R; Beaver C; Ansari R; Pooley R; Wilkinson P; Harper S; Butler AP; Stronach EA; Saez-Rodriguez J; Yusa K; Garnett MJ
BMC Genomics; 2018 Aug; 19(1):604. PubMed ID: 30103702
[TBL] [Abstract][Full Text] [Related]
13. Genome wide-scale CRISPR-Cas9 knockout screens identify a fitness score for optimized risk stratification in colorectal cancer.
Yang X; Liu J; Wang S; Al-Ameer WHA; Ji J; Cao J; Dhaen HMS; Lin Y; Zhou Y; Zheng C
J Transl Med; 2024 Jun; 22(1):554. PubMed ID: 38858785
[TBL] [Abstract][Full Text] [Related]
14. Recovering false negatives in CRISPR fitness screens with JLOE.
Dede M; Hart T
Nucleic Acids Res; 2023 Feb; 51(4):1637-1651. PubMed ID: 36727483
[TBL] [Abstract][Full Text] [Related]
15. MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens.
Li W; Xu H; Xiao T; Cong L; Love MI; Zhang F; Irizarry RA; Liu JS; Brown M; Liu XS
Genome Biol; 2014; 15(12):554. PubMed ID: 25476604
[TBL] [Abstract][Full Text] [Related]
16. BAGEL: a computational framework for identifying essential genes from pooled library screens.
Hart T; Moffat J
BMC Bioinformatics; 2016 Apr; 17():164. PubMed ID: 27083490
[TBL] [Abstract][Full Text] [Related]
17. PICKLES: the database of pooled in-vitro CRISPR knockout library essentiality screens.
Lenoir WF; Lim TL; Hart T
Nucleic Acids Res; 2018 Jan; 46(D1):D776-D780. PubMed ID: 29077937
[TBL] [Abstract][Full Text] [Related]
18. PICKLES v3: the updated database of pooled in vitro CRISPR knockout library essentiality screens.
Novak LC; Chou J; Colic M; Bristow CA; Hart T
Nucleic Acids Res; 2023 Jan; 51(D1):D1117-D1121. PubMed ID: 36350677
[TBL] [Abstract][Full Text] [Related]
19. Measuring error rates in genomic perturbation screens: gold standards for human functional genomics.
Hart T; Brown KR; Sircoulomb F; Rottapel R; Moffat J
Mol Syst Biol; 2014 Jul; 10(7):733. PubMed ID: 24987113
[TBL] [Abstract][Full Text] [Related]
20. CEN-tools: an integrative platform to identify the contexts of essential genes.
Sharma S; Dincer C; Weidemüller P; Wright GJ; Petsalaki E
Mol Syst Biol; 2020 Oct; 16(10):e9698. PubMed ID: 33073517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
